|
|
|
|
|
20.04.26 - 02:18
|
CStone Presented Preclinical Data for Three Novel or Differentiated ADCs at AACR 2026, Including CS5007 (EGFR/HER3) (PR Newswire)
|
|
|
SUZHOU, China, April 19, 2026 /PRNewswire/ -- CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas, today announced that the......
|
|
|
|
|
|
|
|
|
|
|
20.04.26 - 02:06
|
Siemon Releases 2026 ESG Report and Progress Update Report (PR Newswire)
|
|
|
WATERTOWN, Conn., April 19, 2026 /PRNewswire-PRWeb/ -- The Siemon Company, a global leader in high‑performance network infrastructure solutions for data centers and smart buildings, is proud to announce the release of its 2026 Environmental, Social, and Governance (ESG) Report, showcasing......
|
|
|
|
|
20.04.26 - 01:45
|
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit (PR Newswire)
|
|
|
NEW YORK, April 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) between May 20, 2024 and January 9, 2026, inclusive (the "Class Period"), of the important May 22, 2026 lead......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|